|
2025
|
Invention
|
Therapeutic combinations comprising a multi-specific t cell engager. The invention relates to com... |
|
|
Invention
|
Recombinant mesothelin binding proteins and their use. The present invention relates to recombina... |
|
|
Invention
|
Dll3-specific binding constructs and their use in radiotherapy. The present invention relates to ... |
|
|
Invention
|
Recombinant dll3 binding proteins and their use. The present invention relates to recombinant bin... |
|
|
Invention
|
Recombinant cd117 binding proteins and their use. The present invention relates to recombinant bi... |
|
|
Invention
|
Multispecific binding proteins. The present disclosure relates to multispecific binding proteins ... |
|
|
Invention
|
Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent. The prese... |
|
2024
|
Invention
|
Recombinant cd2 binding proteins and their use. The present invention relates to recombinant bind... |
|
|
Invention
|
Recombinant cd47 binding proteins and their use. The present invention relates to recombinant bin... |
|
|
Invention
|
Recombinant cd16a binding proteins and their use. The present invention relates to recombinant bi... |
|
|
Invention
|
Darpins for use in reducing renal accumulation of drugs. The present invention relates to designe... |
|
2023
|
Invention
|
Novel darpin based multi-specific t-cell engagers.
The present invention relates to recombinant ... |
|
|
Invention
|
Multispecific proteins.
This disclosure relates to multispecific recombinant proteins useful for... |
|
|
Invention
|
Charge modified designed repeat domains and their use.
The present invention relates to designed... |
|
|
Invention
|
Charge modified designed repeat domains and their use. The present invention relates to designed ... |
|
|
Invention
|
Recombinant peptide-mhc complex binding proteins and their generation and use.
The present inven... |
|
|
Invention
|
Designed ankyrin repeat domains with altered surface residues.
The present invention relates to ... |
|
2022
|
Invention
|
Designed repeat domains with dual binding specificity and their use.
The present invention relat... |
|
|
Invention
|
Designed repeat domains with dual binding specificity and their use. The present invention relate... |
|
|
Invention
|
Dosing regimens for sars-cov-2 binding molecules. The instant disclosure relates to compositions ... |
|
|
Invention
|
Novel darpin based cd70 engagers.
The present invention relates to recombinant binding proteins ... |
|
|
Invention
|
Novel darpin based cd70 engagers. The present invention relates to recombinant binding proteins c... |
|
|
Invention
|
Novel darpin based cd33 engagers.
The present invention relates to recombinant binding proteins ... |
|
|
Invention
|
Protease cleavable prodrugs.
The application relates to prodrugs comprising a drug molecule conn... |
|
|
Invention
|
Novel darpin based cd123 engagers.
The present invention relates to recombinant binding proteins... |
|
|
Invention
|
Darpin based multi-specific t-cell engagers. The present invention relates to recombinant multi-s... |
|
|
Invention
|
Novel darpin based multi-specific t-cell engagers. The present invention relates to recombinant m... |
|
|
Invention
|
Protease cleavable prodrugs. The application relates to prodrugs comprising a drug molecule conne... |
|
|
Invention
|
Novel darpin based cd33 engagers. The present invention relates to recombinant binding proteins c... |
|
|
Invention
|
Novel darpin based cd123 engagers. The present invention relates to recombinant binding proteins ... |
|
|
Invention
|
Novel ankyrin repeat binding proteins and their uses.
The present invention relates to recombina... |
|
2021
|
Invention
|
Novel slow-release prodrugs.
The present invention relates to compositions comprising a binding ... |
|
|
Invention
|
Recombinant cd3 binding proteins and their use.
The present invention relates to recombinant bin... |
|
|
Invention
|
Novel slow-release prodrugs. in vivoin vivo. The present invention further relates to methods of ... |
|
|
Invention
|
Recombinant cd3 binding proteins and their use. The present invention relates to recombinant bind... |
|
|
Invention
|
Designed ankyrin repeat domains with altered surface residues. The present invention relates to d... |
|
|
Invention
|
Recombinant cd40 binding proteins and their use.
The present invention relates to recombinant bi... |
|
|
Invention
|
Multispecific proteins.
The present invention relates to multispecific proteins comprising desig... |
|
|
Invention
|
Multispecific proteins. The present disclosure relates to multispecific proteins comprising desig... |
|
|
Invention
|
Multispecific proteins. The present invention relates to multispecific proteins comprising design... |
|
|
Invention
|
Recombinant cd40 binding proteins and their use. The present invention relates to recombinant bin... |
|
|
Invention
|
Novel ankyrin repeat binding proteins and their uses. The present invention relates to recombinan... |
|
|
Invention
|
Ankyrin repeat binding proteins and their uses. The present invention relates to recombinant bind... |
|
2020
|
Invention
|
Recombinant peptide-mhc complex binding proteins and their generation and use. The present invent... |
|
|
Invention
|
Designed ankyrin repeat domain with improved stability.
The present disclosure relates to design... |
|
|
Invention
|
Recombinant 4-1bb binding proteins and their use.
The present disclosure relates to recombinant ... |
|
|
Invention
|
Recombinant fap binding proteins and their use.
The present disclosure relates to recombinant bi... |
|
2019
|
G/S
|
Pharmaceutical preparations for the treatment of macular degeneration. |
|
2008
|
G/S
|
Chemical, biochemical, biological and biotechnological
preparations for industrial and scientifi... |
|
|
G/S
|
Chemical, biochemical, biological and biotechnological preparations for industrial and scientific... |
|
|
G/S
|
Chemical, biochemical, biological and biotechnological
preparations for industrial or scientific... |
